ahlam1399
05-22-2015, 02:48 AM
Oto**my?s ear drug fails mid-stage trial, shares slide
(Reuters) - Oto**my Inc said its experimental drug did **t meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4688eb3c/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/ach.img (http://adchoice.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/ach.htm)http://pi.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2t.imghttp://pi2.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=M0SYTZC0fAE:Nx9lr9Z7TVo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=M0SYTZC0fAE:Nx9lr9Z7TVo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/M0SYTZC0fAE
(Reuters) - Oto**my Inc said its experimental drug did **t meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4688eb3c/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2.img (http://da.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/ach.img (http://adchoice.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/ach.htm)http://pi.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2t.imghttp://pi2.feedsportal.com/r/228766200819/u/49/f/654207/c/35217/s/4688eb3c/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=M0SYTZC0fAE:Nx9lr9Z7TVo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=M0SYTZC0fAE:Nx9lr9Z7TVo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=M0SYTZC0fAE:Nx9lr9Z7TVo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/M0SYTZC0fAE